{"changes":[],"country":"US","description":"Triana Biomedicines develops molecular glue degraders, small molecules that force a disease-causing protein together with the cell's degradation machinery. It targets cancer patients whose disease is driven by proteins long considered undruggable. Its protein-pairing engine identifies matching E3 ligases, engineering glues rationally not by chance.","domain":"trianabio.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":38.046407,"lng":-84.497039,"location":"Lexington, United States","name":"Triana Biomedicines","rounds":[{"amountQuarantined":false,"amountUsd":120000000,"currency":"USD","date":"2025-12-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"trianabio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},{"fact":"existence","publisher":"trianabio.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://trianabio.com"},{"fact":"description","publisher":"trianabio.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://trianabio.com"}],"stage":"series-b+","techStack":["Typekit","Adobe Fonts","Afterpay","Sentry","Squarespace","Squarespace Commerce","Stimulus","web-vitals","moment 0","@sentry/browser"],"totalRaisedUsd":230000000,"updatedAt":"2026-04-29"}